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Background: This study investigated the mid-term (mean, 3.7 years) clinical results and the results of duplex Doppler
sonographic examinations of subfascial endoscopic perforating vein surgery (SEPS) in patients with mild to severe
chronic venous insufficiency (clinical class 2-6) and assessed the factors associated with the recurrence of insufficient
perforating veins (IPVs).
Methods: Eighty patients with mild to severe chronic venous insufficiency undergoing SEPS were evaluated, and duplex
findings, as well as clinical severity and disability scores before and after the operation, were compared. Patients with prior
deep vein thrombosis (<6 months) or prior SEPS were excluded from this study.
Results: There were 27 men and 53 women with a median age of 59.8 years (range, 34.3-80.0 years). The distribution of
clinical classes (CEAP) was as follows: class 2, 13.1% (12 limbs); class 3, 22.8% (21 limbs); class 4, 19.6% (18 limbs); class
5, 21.7% (20 limbs); and class 6, 22.8% (21 limbs). The etiology of venous insufficiency was primary valvular
incompetence in 83 limbs (90.2%) and secondary disease in 9 limbs (9.8%). Concomitant superficial vein surgery was
performed in 89 limbs (95.7%). Twenty (95%) leg ulcers healed spontaneously within 12 weeks after operation, whereas
one patient required additional split-thickness skin grafting. Eighteen patients had previous surgery of the great and/or
short saphenous vein before SEPS. During a mean follow-up of 3.7 years, recurrence of 22 IPVs was observed in 20
(21.7%) of 92 limbs, and recurrent leg ulcers were observed in 2 (9.5%) of 21 limbs. We performed univariate and
multivariate analyses to predict factors influencing the recurrence of IPVs (recurrent superficial varicosis, secondary
disease, active or healed leg ulcer [C5/6], compression treatment, and previous operation). On multivariate analysis,
previous surgery (P  .014) was identified as the only significant factor for the recurrence of IPVs.
Conclusions: SEPS is a safe and highly effective treatment for IPVs. Within a median follow-up period of 3.7 years, only
2 of 21 venous ulcers recurred, both in patients with secondary disease. Nevertheless, we observed recurrence of IPVs in
21.7% of the operated limbs. On multivariate analysis, patients who had undergone previous surgery were found to have
a significantly higher rate of recurrence. ( J Vasc Surg 2006;44:359-63.)Since its first description by Hauer1 in the 1980s,
subfascial endoscopic perforating vein surgery (SEPS) has
been accepted as an improved treatment concept in the
surgical treatment of perforator vein insufficiency, particu-
larly in cases of advanced skin changes. SEPS is performed
in many centers as a component of a comprehensive treat-
ment program for venous insufficiency.2
Randomized trials have demonstrated comparable ef-
fectiveness but significantly less morbidity with SEPS.2
SEPS in combination with stripping of the great saphenous
vein (GSV) has been shown to accelerate ulcer healing3 and
to reduce the incidence of new and recurrent ulcers4 com-
pared with the best medical management alone.5 The indi-
cation for interruption of perforators in varicose vein sur-
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doi:10.1016/j.jvs.2006.04.028gery is controversial, but the suggested benefit may be the
prevention of recurrences.6,7
The purpose of this study was to evaluate the recur-
rence rate of insufficient perforating veins (IPVs) in patients
undergoing SEPS with or without concomitant superficial
vein surgery. Medical records were studied to identify
possible risk factors for recurrence at the time of the pri-
mary operation.
PATIENTS AND METHODS
Eighty patients (92 limbs) who had undergone SEPS
with or without concomitant superficial vein ablation be-
tween May 1997 and February 2002 were retrospectively
analyzed. Preoperative assessment included a history, clin-
ical examination, and color-coded duplex sonography
(ATL/Ultramark9, Philips, Koninklijke, The Nether-
lands). IPVs were marked the day before surgery by duplex
scan. These examinations were redone 1 week after SEPS
and likewise at irregular postoperative intervals (6
months). Patients with evidence of arterial insufficiency or
recent (6 months) deep venous thrombosis were ex-
cluded.
Incompetent perforators were classified as insufficient
if the diameter of the vein at the level of the fascia exceeded
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decision for SEPS was made either on the basis of the
number of perforators or progressive skin changes. Patients
with varicose veins only (C2) received SEPS treatment only
if preoperative duplex scan revealed three or more IPVs. A
mean of 2.5 (range: 1-6) perforating veins per leg were
coagulated and divided under video assistance. These in-
cluded paratibial perforators and posterior tibial perfora-
tors. Because the endoscope is not accessible to the retro-
malleolar region, medial ankle perforators were disregarded
in our study. A Storz 10-mm endoscope attached to a video
camera (Karl Storz, Tüttlingen, Germany) was used in
conjunction with the basic SEPS technique as described by
Fischer et al.9 Concomitant fasciotomy was performed in
10 limbs (10.9%; 10 patients).
In the case of venous ulcers, compression treatment was
continued until healing was completed. Patients with sec-
ondary disease were advised to wear compression stockings
indefinitely. Clinical severity and disability scores as pro-
posed by the American Venous Forum Executive Commit-
tee were registered before and after surgery.10,11
Continuous data were compared by using the t test or
the Mann-Whitney test, where appropriate, and the 2 test
was used for the comparison of proportions. Survival anal-
yses were performed according to the method described by
Kaplan and Meier. A Cox proportional hazard analysis was
used for multivariate analysis to explore the effect of vari-
ables on disease-free survival. All statistical analyses were
undertaken by using the SPSS 10.0 software package (SPSS
Inc, Chicago, Ill). All given P values are two tailed, and a
P value of .05 was regarded to indicate statistical
significance.
RESULTS
Limbs were classified according to the CEAP classifica-
tion, as shown in Table I. There were 27 men and 53
women with a median age of 59.8 years (range: 34.3-80.0
years). Superficial reflux exceeding 0.5 seconds was con-
Table I. Patient characteristics according to the CEAP
classification
Variable No. Limbs %
Clinical signs (1-6)
(2) Varicose veins 12 13.1
(3) Edema without skin changes 21 22.8
(4) Skin changes ascribed to venous disease 18 19.6
(5) Skin changes with healed ulceration 20 21.7
(6) Skin changes with active ulceration 21 22.8
Etiology
Primary venous insufficiency 83 90.2
Secondary venous insufficiency 9 9.8
Anatomic distribution
Deep-system incompetence 9 9.8
Superficial-system incompetence 91 98.9
Perforator-system incompetence 92 100
Pathophysiologic dysfunction
Reflux disease 92 100firmed in 89 (96.7%) of 92 limbs. The etiology of venousinsufficiency was primary valvular incompetence in 83 limbs
(90.2%) and secondary disease in 9 limbs (9.8%). Concom-
itant major superficial vein ablation was performed in 89
limbs (96.7%): 71 GSVs, 4 short saphenous veins, 8 com-
bined great and short saphenous veins, and 10 revisions of
the saphenofemoral junction. In three limbs, SEPS was the
only procedure performed. Eighteen patients (24 limbs;
25.8%) had previously undergone major vein surgery (GSV,
small saphenous vein, or both). For details, see Table II.
At the time of the operation, 21 limbs (22.8%) pre-
sented with active ulceration. These ulcers had been uni-
formly present for more than 12 weeks. Twenty (95%) of
these healed by the 12th postoperative week, whereas one
patient required additional split-thickness skin grafting.
Postoperative complications were uncommon and con-
sisted of wound infection or wound dehiscence in five
patients and major subfascial hematoma in one patient.
During a mean follow-up period of 3.7 years (range,
1.2-7.0 years), 22 recurrent IPVs were observed in 20
(21.7%) of 92 limbs (Fig 1). None of the current perforat-
ing veins had been present at duplex scan 1 week after
surgery. In the case of primary venous insufficiency, 17
(20.5%) of 83 limbs tested positive for recurrent IPVs,
compared with 3 (33.3%) of 9 limbs in patients with
secondary disease. The distribution between the different
clinical classes is shown in Table III. Among patients with
early disease (C2), only 1 patient (8.3%) developed recur-
rence of IPVs, compared with 9 recurrences (22.0%) in 41
limbs of patients with healed or active leg ulcers (C5/6).
Table II. Surgical procedures in patients with previous
superficial vein surgery requiring SEPS
Patient
No. Previous operation Reoperation
1 GSV stripping SFJ revision, SSV stripping,
SEPS
2 GSV stripping SFJ revision, SEPS




4 GSV stripping SSV stripping, SEPS
5 GSV stripping SFJ revision, SEPS
6 GSV stripping SEPS
7 GSV, SSV stripping SEPS
8 GSV, SSV stripping SFJ revision, SEPS
9 GSV stripping SSV stripping, SEPS
10 GSV stripping SSV stripping, SEPS
11 GSV stripping SFJ revision, SEPS
12 GSV, SSV stripping SEPS
13 SSV stripping GSV stripping, SEPS
14 SFJ ligation SFJ revision, stripping
(GSV  SSV)
15 SSV stripping, SFJ
ligation
SFJ revision, GSV stripping
16 GSV stripping SFJ revision, SSV stripping
17 SFJ ligation SFJ revision, GSV stripping
18 SFJ ligation SFJ revision, GSV stripping
SEPS, Subfascial endoscopic perforating vein surgery; GSV, great saphenous
vein; SFJ, saphenofemoral junction; SSV, small saphenous vein.Six (26%) of 23 patients with clinically recurrent superficial
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patients who were noncompliant with compression ther-
apy. The highest rates of recurrence were found in patients
who had undergone previous vein surgery (9 [37.5%]
of 24; Table IV).
To identify predictors for the recurrence of IPVs, we
performed univariate and multivariate analyses that in-
cluded the following parameters: recurrent varicose veins,
secondary disease, active or healed leg ulcer (C5/6), lack of
compression treatment, and previous surgery. Univariate
analysis revealed that none of these factors was significant
for the development of recurrent IPVs after SEPS. How-
ever, on multivariate logistic regression analysis, previous
surgery was identified as the only independent risk factor
for relapse. As shown in Fig 2., patients without previous
surgery had a significantly longer disease-free survival as
compared with patients who had undergone (repeated)
previous surgery.
During the observation period, recurrent ulceration
was observed in two patients, both of whom had secondary
venous disease. One of these patients tested positive for
recurrent IPVs. Both patients underwent repeated skin
grafting and were healed at the time of examination.
The clinical score and disability score before surgery were
5.96 and 1.94, respectively, vs 2.1 and 0.56 at follow-up. For
patients with recurrent IPVs, mean clinical and disability
scores were 5.5 and 1.8, respectively, before operation and
2.0 and 0.6 at follow-up. The respective values for patients
Fig 1. Kaplan-Meier curves for insufficient perforating vein–free
survival.without evidence of recurrent IPVs were 5.9 and 2.2,respectively, before operation and 1.8 and 0.5 at follow-up
(not significant).
DISCUSSION
Despite extensive interest in the contribution of perfo-
rating veins to chronic venous insufficiency, their hemody-
namic role remains controversial.12-14 Still, their prevalence
increases linearly with the clinical severity of chronic venous
insufficiency, stratified according to the CEAP classifica-
tion.15 They not only increase in number, but also progres-
sively dilate.16 This suggests a secondary phenomenon due
to recirculating blood volumes, which increase venous pres-
sure. The necessity for surgical correction of incompetent
perforator veins has been debated for years.17,18
It has been shown that after elimination of saphenous
reflux, IPVs regain competence as a result of the normal-
ization of venous circulation.19,20 This might hold true for
uncomplicated primary venous insufficiency (C2), because
compromised valves may regain function after major sites of
reflux have been removed. In case of progressive disease,
including patients with chronic skin changes, perforating
veins remain incompetent in 25.5% of patients even after
elimination of superficial venous reflux.20 Stuart et al21
confirmed that eradication of the main stem saphenous
reflux corrected perforator vein reflux only if reflux was
confined to the superficial system. However, in case of
coexisting deep venous reflux, the correction of perforator
vein reflux failed.
The clinical value of perforator vein surgery has been
shown for progressive venous disease.13 In these patients,
the most reliable and careful way of correcting pathologic
outward flow is SEPS. Because of the avoidance of incisions
in an area of already-compromised skin, wound complica-
tions can be dramatically reduced as compared with trans-
cutaneous surgery. Proebstle et al22 reported 40 limbs that
were treated by superficial reflux ablation earlier without
effect; the SEPS procedure resulted in hemodynamic im-
provement in 58%. Nine of 16 ulcers that had been active
for up to 21 years healed within 14 to 50 days. Although, in
most studies, the outcome of SEPS is masked by the
overlapping beneficial effect of concomitant superficial vein
surgery, cumulative ulcer healing rates of up to 88% have
been reported after SEPS.13,23-25
In our study, the accuracy of SEPS was confirmed by
preoperative duplex mapping of insufficient perforator
Table III. Incidence of recurrent IPVs according to the
CEAP classification
Clinical class No. Limbs with IPVs %
2 (varicose veins) 1 8.3
3 (edema) 5 23.8
4 (skin changes) 5 27.8
5 (skin changes and healed ulcer) 4 20.0
6 (skin changes and active ulcer) 5 23.8
IPV, Insufficient perforating vein.veins, which were all accessible to SEPS. It is possible that
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impaired by minor hematoma in the subfascial space. How-
ever, no perforator veins meeting the criteria for insuffi-
ciency, as mentioned previously, were noticed at that time.
Notwithstanding, reassessment of the medial leg perfo-
rators by duplex sonography after a median follow-up
period of 3.7 years revealed 22 IPVs in 20 (21.7%) of 92
limbs. After conventional transcutaneous surgery, Blomgren
et al17 reported a recurrence rate of 41% after 2 years and
32% after 2 months. Possibly, recurrent IPVs after transcu-
taneous dissection are not true recurrences but can partly
be attributed to incomplete surgical removal because per-
forating veins can easily be confounded with tributaries in
this area. This might explain why dissection of IPVs subfas-
cially under video guidance can be performed with superior
accuracy.
In our study, the recurrence rate of IPVs was low in
patients with varicose veins only (C2; 8.3%) and leveled off
in patients with increasing severity of venous disease (C3-6;
20.7%). Comparing the recurrence rates between patients
Table IV. Factors influencing IPV recurrence and statistic
Variable Recurrence %
Recurrence of varicose veins 6 26
Secondary disease 3 33
C5/6 9 22
Previous operation 9 37
Lack of compression therapy 18 23
IPV, Insufficient perforating vein.
Fig 2. Kaplan-Meier curves for insufficient perforating vein–free
survival. Patients with previous surgery (dashed line) had a shorter
disease-free survival than patients without previous surgery
(straight line).with primary venous insufficiency and secondary disease,the respective values were 21.7% and 33%. Multivariate
analysis included accepted risk factors for severity or pro-
gression of venous disease. On multivariate analysis, only
patients who had undergone previous vein surgery had a
statistically higher risk of developing IPVs. This is not
surprising, because this group of patients often experiences
venous disorders for a prolonged period of time; therefore,
the likelihood of regression of morphologic and hemody-
namic changes decreases with time.
The main finding in this study is that, although SEPS is
the superior procedure in eradication of IPV, it does not
prevent IPV recurrence. Recurrence rates of 33% in second-
ary disease might partly be explained by the persistence of
deep venous reflux. However, in primary disease, recur-
rence rates of 21.7% are most likely associated with progres-
sion of the disease. In our study, quality of life, as assessed
by measuring the clinical score and disability score, im-
proved dramatically and was long-lasting after corrective
vein surgery. This might be independent of IPV recurrence
and underscores the superior importance of axial vein reflux
correction compared with perforator vein surgery. This
finding is also supported by the recurrence of only 2 of 21
ulcers in the observation period. Whereas both cases fea-
tured deep venous reflux, perforator vein recurrence was
noted in one patient.
Still, in patients with venous leg ulcers, elimination of
all identifiable incompetent transfascial connections should
be sought, as should axial reflux correction to optimize ve-
nous flow and pressure. Even if this condition can be achieved
for only a limited time, this might suffice to provide ulcer
healing.25 This concept could also be confirmed by our
findings, because 20 (95%) of 21 chronic venous ulcers
healed within 12 weeks after surgery.
CONCLUSION
Although SEPS is associated with a lower recurrence
rate of IPVs compared with conventional transcutaneous
surgery, it does not prevent disease progression. Multivar-
iate analysis identified previous vein surgery to be associated
with a statistically higher risk for the development of IPVs.
Nevertheless, recurrence of IPVs did not affect quality of
life, which significantly improved after treatment of reverse
flow in the superficial and perforator system. In patients
with venous leg ulcer, SEPS in addition to superficial reflux
ablation promotes ulcer healing and results in a low mid-
term ulcer recurrence rate due to meticulous elimination of
nificance on multivariate analysis
No recurrence % P value Exp (B)
17 74 .287 0.520
6 67 .237 2.817
32 78 .129 2.103
15 63 .014 3.690
58 77 .919 1.060al sigpathologic venous flow.
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